(Q83300232)
Statements
Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence (English)
Kenneth H Mayer
Matthew J Mimiaga
Marcy Gelman
scientific article published on 01 April 2012